Cargando…

Dose Adjustment of Concomitant Antiseizure Medications During Cenobamate Treatment: Expert Opinion Consensus Recommendations

INTRODUCTION: Our objective was to provide expert consensus recommendations to improve treatment tolerability through dose adjustments of concomitant antiseizure medications (ASMs) during addition of cenobamate to existing ASM therapy in adult patients with uncontrolled focal seizures. METHODS: A pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Smith, Michael C., Klein, Pavel, Krauss, Gregory L., Rashid, Samiya, Seiden, Lawrence G., Stern, John M., Rosenfeld, William E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9588096/ https://www.ncbi.nlm.nih.gov/pubmed/36057761 http://dx.doi.org/10.1007/s40120-022-00400-5

Ejemplares similares

Post hoc analysis of a phase 3, multicenter, open‐label study of cenobamate for treatment of uncontrolled focal seizures: Effects of dose adjustments of concomitant antiseizure medications
por: Rosenfeld, William E., et al.
Publicado: (2021)

The Pharmacology and Clinical Efficacy of Antiseizure Medications: From Bromide Salts to Cenobamate and Beyond
por: Löscher, Wolfgang, et al.
Publicado: (2021)

Pharmacokinetics and safety of cenobamate, a novel antiseizure medication, in healthy Japanese, and an ethnic comparison with healthy non‐Japanese
por: Yang, Eunsol, et al.
Publicado: (2021)

Randomized phase 2 study of adjunctive cenobamate in patients with uncontrolled focal seizures
por: Chung, Steve S., et al.
Publicado: (2020)

Efficacy of cenobamate for uncontrolled focal seizures: Post hoc analysis of a Phase 3, multicenter, open‐label study
por: Sperling, Michael R., et al.
Publicado: (2021)

Cenobamate (YKP3089) as adjunctive treatment for uncontrolled focal seizures in a large, phase 3, multicenter, open‐label safety study
por: Sperling, Michael R., et al.
Publicado: (2020)

Onset of efficacy and adverse events during Cenobamate titration period
por: Steinhoff, Bernhard J., et al.
Publicado: (2022)

Suppression of the photoparoxysmal response in photosensitive epilepsy with cenobamate (YKP3089)
por: Kasteleijn- Nolst Trenite, Dorothee G.A., et al.
Publicado: (2019)

Long-term Efficacy and Safety From an Open-Label Extension of Adjunctive Cenobamate in Patients With Uncontrolled Focal Seizures
por: Klein, Pavel, et al.
Publicado: (2022)

Opinion-Based Recommendations: Beware the Tyranny of Experts
por: Spellberg, Brad, et al.
Publicado: (2021)

Long‐term safety of adjunctive cenobamate in patients with uncontrolled focal seizures: Open‐label extension of a randomized clinical study
por: French, Jacqueline A., et al.
Publicado: (2021)

Is Cenobamate the Breakthrough We Have Been Wishing for?
por: Specchio, Nicola, et al.
Publicado: (2021)

Souvenaid in the management of mild cognitive impairment: an expert consensus opinion
por: Cummings, Jeffrey, et al.
Publicado: (2019)

Expert Opinions and Consensus Recommendations for the Evaluation and Management of Insomnia in Clinical Practice: Joint Statements of Five Italian Scientific Societies
por: Palagini, Laura, et al.
Publicado: (2020)

Chronic Q Fever Diagnosis—Consensus Guideline versus Expert Opinion
por: Kampschreur, Linda M., et al.
Publicado: (2015)

COVID‐19: Review of European recommendations and experts’ opinion on dental care. Summary and consensus statements of group 5. The 6th EAO Consensus Conference 2021
por: Gurzawska‐Comis, Katarzyna, et al.
Publicado: (2021)

Long‐term individual retention with cenobamate in adults with focal seizures: Pooled data from the clinical development program
por: Sander, Josemir W., et al.
Publicado: (2021)

Perampanel as first add-on antiseizure medication: Italian consensus clinical practice statements
por: Bonanni, Paolo, et al.
Publicado: (2021)

An Ex Vivo Evaluation of Cenobamate Administered via Enteral Tubes
por: Ferrari, Louis, et al.
Publicado: (2020)

Critical Appraisal of Cenobamate as Adjunctive Treatment of Focal Seizures in Adults
por: Zaccara, Gaetano, et al.
Publicado: (2021)

Real-World Experience Treating Pediatric Epilepsy Patients With Cenobamate
por: Makridis, Konstantin L., et al.
Publicado: (2022)

Cenobamate in refractory epilepsy: Overview of treatment options and practical considerations
por: Schmitz, Bettina, et al.
Publicado: (2023)

Experts Opinion
por: Goldberg, Ivan, et al.
Publicado: (2012)

Expert Opinion
Publicado: (1920)

Use of sexual stimuli in research and clinical settings: expert opinion and recommendations
por: Katz, Maddie A, et al.
Publicado: (2023)

Expert Opinion on Pegloticase with Concomitant Immunomodulatory Therapy in the Treatment of Uncontrolled Gout to Improve Efficacy, Safety, and Durability of Response
por: Botson, John K., et al.
Publicado: (2022)

IncobotulinumtoxinA in aesthetics: Russian multidisciplinary expert consensus recommendations
por: Yutskovskaya, Yana, et al.
Publicado: (2015)

Treatment of Soft Tissue Filler Complications: Expert Consensus Recommendations
por: Urdiales-Gálvez, Fernando, et al.
Publicado: (2018)

Expert consensus recommendations to improve diagnosis of ATTR amyloidosis with polyneuropathy
por: Adams, David, et al.
Publicado: (2020)

Proposed Recommendations for the Management of Depression in Adults with Epilepsy: An Expert Consensus
por: Villanueva, Vicente, et al.
Publicado: (2023)

Does Adjustment of Antiseizure Medication Regimen after Failed Epilepsy Surgery Improve Outcomes?
por: Wu, Yuxin, et al.
Publicado: (2023)

Correction: Perampanel as first add-on antiseizure medication: Italian consensus clinical practice statements
por: Bonanni, Paolo, et al.
Publicado: (2022)

Cenobamate for treatment-resistant focal seizures: current evidence and place in therapy
por: Singh, Alok
Publicado: (2022)

Anticonvulsant effects of cenobamate in chemically and electrically induced seizure models in rodents
por: Melnick, Susan M., et al.
Publicado: (2023)

Cenobamate (YKP3089) and Drug-Resistant Epilepsy: A Review of the Literature
por: Rissardo, Jamir Pitton, et al.
Publicado: (2023)

The Development of Practice Recommendations for Drug-Disease Interactions by Literature Review and Expert Opinion
por: van Tongeren, Justine M. Z., et al.
Publicado: (2020)

Navigating the Regulatory Landscape to Develop Pediatric Oncology Drugs: Expert Opinion Recommendations
por: Barry, Elly, et al.
Publicado: (2021)

Teratogenicity and Antiseizure Medications
por: Meador, Kimford
Publicado: (2020)

Antiseizure medications and pregnancy
por: Moores, Ginette, et al.
Publicado: (2021)

Neuropharmacology of Antiseizure Drugs
por: Hakami, Tahir
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9a3tepuks73245njgp3ijip1fd